Search for: "RENAL PHYSICIANS ASSOCIATION" Results 61 - 80 of 113
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Jan 2013, 9:11 am by Jon Gelman
Pay close attention to signs and symptoms that may be associated with metal-on-metal hip implants. [read post]
9 Jan 2013, 10:43 pm
While they indicate that no one knows for sure how often dislodged tubes or line separations occur, a 2007 safety survey conducted by the Renal Physicians Association did reveal that it wasn't uncommon for the needle to dislodge during treatment. [read post]
19 Oct 2012, 7:37 am by Ed Wallis
The findings were supported by a report published in the January 2012 issue of the American Heart Association Journal. [read post]
19 Oct 2012, 7:32 am by Ed Wallis
In addition, drug companies and physicians must provide adequate warning of potential risks of any drug. [read post]
18 Oct 2012, 6:20 am by Ed Wallis
Heart Stroke A meta-analysis published by the American Heart Association in January 2012 confirmed the enhanced risk of heart attacks associated with Pradaxa side effects. [read post]
18 Oct 2012, 6:18 am by Ed Wallis
The conditions of patients with prior renal impairment are likely to deteriorate with the drug side effects. [read post]
28 Aug 2012, 9:33 am by Mark Zamora
  This could lead to metabolic alkalosis, a risk associated with low blood pressure, hypoxemia, hypercapnia, hypokalemia and cardiac arrhythmia. [read post]
28 Aug 2012, 9:33 am by Mark Zamora
  This could lead to metabolic alkalosis, a risk associated with low blood pressure, hypoxemia, hypercapnia, hypokalemia and cardiac arrhythmia. [read post]
23 Aug 2012, 2:29 pm by Brenda Fulmer
  This Japanese safety alert urged physicians to look for signs of anemia and bleeding in the body (not just gastric or GI bleeding) and to perform renal function testing on patients in hopes of avoiding administration to vulnerable patients with underlying (and perhaps undiagnosed) renal insufficiency. [read post]
1 Jul 2012, 2:59 am
Food and Drug Administration practice of valuing all deaths at a an estimate of $7.9 million (in 2009 U.S. dollars).Cost of medical treatment included physician and emergency room visits, hospitalization, outpatient treatment, and long-term care for permanent or chronic conditions, with costs of hospitalization the most significant. [read post]
14 Jun 2012, 10:23 am
Victoza, one of newer diabetes drug has been associated with a number of serious side effects including Thyroid Cancer, Renal (Kidney) Failure and Pancreatitis. [read post]
26 May 2012, 7:49 am by PritzkerLaw
A new study out of Europe showed that 30 percent of HUS patients developed hypertension, impaired renal function or neurologic dysfunction by the five-year follow-up with their physician. [read post]
26 May 2012, 7:49 am by PritzkerLaw
A new study out of Europe showed that 30 percent of HUS patients developed hypertension, impaired renal function or neurologic dysfunction by the five-year follow-up with their physician. [read post]
11 May 2012, 6:52 am by Craig Kelley
In addition, Pradaxa is processed by the kidneys, which means that by assessing your renal function, a physician can monitor your dosage of Pradaxa. [read post]
11 May 2012, 6:52 am by Craig Kelley
In addition, Pradaxa is processed by the kidneys, which means that by assessing your renal function, a physician can monitor your dosage of Pradaxa. [read post]
16 Feb 2012, 3:57 pm
Everolimus, also known by the brand name Afinitor, is a relatively new drug that has been used by cancer doctors since 2009 to treat advanced renal cell carcinoma (cancer of the kidney). [read post]
7 Feb 2012, 5:01 pm by Oliver G. Randl
Both the patent proprietor and the opponent filed an appeal against the decision of the Opposition Division (OD) to maintain the patent under consideration in amended form. [read post]
10 Jan 2012, 2:07 pm by Ed Wallis
Because of the decrease in renal function that occurs with normal aging, the elderly are at greater risk for digoxin toxicity. [read post]
6 Jan 2012, 1:28 pm
Indeed, Novartis paid physician speakers to hold "unbranded" speaker series supporting the Tekturna family of brands in order to promote Tekturna, TekturnaHCT, Valturna, TekAmlo and Amturnide to the diabetic patient population. [read post]